- Home
- DNLI vs CRGY Comparison
DNLI vs CRGY Comparison
Compare DNLI & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNLI | CRGY |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.8B |
| IPO Year | 2017 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DNLI | CRGY |
|---|---|---|
| Price | $24.92 | $14.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 12 |
| Target Price | ★ $34.33 | $14.73 |
| AVG Volume (30 Days) | 1.3M | ★ 5.6M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,579,782,000.00 |
| Revenue This Year | N/A | $29.70 |
| Revenue Next Year | $408.85 | N/A |
| P/E Ratio | ★ N/A | $99.08 |
| Revenue Growth | N/A | ★ 22.14 |
| 52 Week Low | $12.58 | $7.68 |
| 52 Week High | $27.30 | $14.29 |
Technical Indicators
Market Signals| Indicator | DNLI | CRGY |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 76.36 |
| Support Level | $22.32 | $11.45 |
| Resistance Level | $25.74 | $14.05 |
| Average True Range (ATR) | 0.83 | 0.44 |
| MACD | 0.03 | 0.22 |
| Stochastic Oscillator | 62.75 | 97.50 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About CRGY Crescent Energy Company
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The company operates in one reportable segment, which is the exploration and production of crude oil, natural gas, and NGLs.